Skip to main content
OpenTrials

Clinical trial condition

Acute Myeloid Leukemia

Explore clinical trials studying Acute Myeloid Leukemia. Study availability and eligibility vary by location and protocol.

1,026 public trials 279 recruiting studies
Refine in advanced search Browse all conditions

Acute Myeloid Leukemia trial results

Recruiting

Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

NCT06824168

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • John Hopkins School of Medicine Baltimore, Maryland, United States
  • Umass Memorial Health Care Systems Worcester, Massachusetts, United States
  • Roswell Park Cancer Institute Buffalo, New York, United States
  • Weill Cornell New York, United States
View all 64 locations
View Trial Details
Recruiting

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

NCT04065399

Conditions
Acute Leukemia of Ambiguous Lineage, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, +16 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • University Of California Care Medical Group - Norris Comprehensive Cancer Center And Hospital Los Angeles, California, United States
  • Stanford Cancer Institute Palo Alto, California, United States
  • University of Colorado Aurora, Colorado, United States
View all 57 locations
View Trial Details
Recruiting

A Study of BGB-11417 in Participants With Myeloid Malignancies

NCT04771130

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +9 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Tampa General Hospital Tampa, Florida, United States
  • Upmc Hillman Cancer Center(Univ of Pittsburgh) Pittsburgh, Pennsylvania, United States
  • Md Anderson Cancer Center Houston, Texas, United States
View all 47 locations
View Trial Details
Recruiting

Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies

NCT03471260

Conditions
Acute Myeloid Leukemia, Bone Marrow Diseases, Hematologic Diseases, +13 more
Locations
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
  • Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center Cleveland, Ohio, United States
  • Oregon Health and Science University Portland, Oregon, United States
  • M D Anderson Cancer Center Houston, Texas, United States
View Trial Details
Recruiting

Study to Assess Adverse Events and Change in Disease Activity of Oral Venetoclax in Combination With Subcutaneous (SC) or Intravenous (IV) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Standard Induction Therapy in India

NCT07044687

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • Fortis Memorial Research Institute /ID# 268697 Gurgaon, Haryana, India
  • Mazumdar Shaw Medical Center /ID# 270677 Bengaluru, Karnataka, India
  • Regional Cancer Centre /ID# 268785 Thiruvananthapuram, Kerala, India
  • LMMF's Deenanath Mangeshkar Hospital & Research Center /ID# 268781 Pune, Maharashtra, India
View all 14 locations
View Trial Details
Recruiting

A Study to Assess the Safety, Tolerability, and Antileukemic Activity of Debio 1562M in Participants With Acute Myeloid Leukemia (AML)

NCT06969430

Conditions
Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +5 more
Locations
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • Moffitt Cancer Center and Research Institute Hospital Tampa, Florida, United States
  • University of Chicago Chicago, Illinois, United States
  • START Midwest Grand Rapids, Michigan, United States
View Trial Details

Related conditions